Why Is Dianthus Therapeutics Stock Trading Higher On Friday? - Dianthus Therapeutics (NASDAQ:DNTH)

Dianthus reports 75% responder rate for claseprubart in CIDP, while analysts say Sanofi's riliprubart faces rising risks after MOBILIZE.

Raccontata dabenzinga.com